Proton pump inhibitor use: systematic review of global trends and practices

Purpose Proton pump inhibitors (PPIs) reduce acid secretion in the stomach and rank as one of the most widely used acid-suppressing medicines globally. While PPIs are safe in the short-term, emerging evidence shows risks associated with long-term use. Current evidence on global PPI use is scarce. Th...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of clinical pharmacology Vol. 79; no. 9; pp. 1159 - 1172
Main Authors Shanika, Lelwala Guruge Thushani, Reynolds, Andrew, Pattison, Sharon, Braund, Rhiannon
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.09.2023
Springer Nature B.V
Subjects
Adult
Biomedical and Life Sciences
Biomedicine
Catalysts
Female
Health Care Costs
Humans
Male
Pharmacology/Toxicology
Prescriptions
Proton pump inhibitors
Proton Pump Inhibitors - adverse effects
Review
Reviews
Systematic review
Upper Gastrointestinal Tract
Global use
Proton pump inhibitors
Systematic review
Dose
Long term
Online AccessGet full text

Cover

Abstract Purpose Proton pump inhibitors (PPIs) reduce acid secretion in the stomach and rank as one of the most widely used acid-suppressing medicines globally. While PPIs are safe in the short-term, emerging evidence shows risks associated with long-term use. Current evidence on global PPI use is scarce. This systematic review aims to evaluate global PPI use in the general population. Methods Ovid MEDLINE, Embase, and International Pharmaceutical Abstracts were systematically searched from inception to 31 March 2023 to identify observational studies on oral PPI use among individuals aged ≥ 18 years. PPI use was classified by demographics and medication factors (dose, duration, and PPI types). The absolute numbers of PPI users for each subcategory were summed and expressed as a percentage. Results The search identified data from 28 million PPI users in 23 countries from 65 articles. This review indicated that nearly one-quarter of adults use a PPI. Of those using PPIs, 63% were less than 65 years. 56% of PPI users were female, and “White” ethnicities accounted for 75% of users. Nearly two-thirds of users were on high doses (≥ defined daily dose (DDD)), 25% of users continued PPIs for > 1 year, and 28% of these continued for > 3 years. Conclusion Given the widespread use PPIs and increasing concern regarding long-term use, this review provides a catalyst to support more rational use, particularly with unnecessary prolonged continuation. Clinicians should review PPI prescriptions regularly and deprescribe when there is no appropriate ongoing indication or evidence of benefit to reduce health harm and treatment cost.
AbstractList Purpose Proton pump inhibitors (PPIs) reduce acid secretion in the stomach and rank as one of the most widely used acid-suppressing medicines globally. While PPIs are safe in the short-term, emerging evidence shows risks associated with long-term use. Current evidence on global PPI use is scarce. This systematic review aims to evaluate global PPI use in the general population. Methods Ovid MEDLINE, Embase, and International Pharmaceutical Abstracts were systematically searched from inception to 31 March 2023 to identify observational studies on oral PPI use among individuals aged ≥ 18 years. PPI use was classified by demographics and medication factors (dose, duration, and PPI types). The absolute numbers of PPI users for each subcategory were summed and expressed as a percentage. Results The search identified data from 28 million PPI users in 23 countries from 65 articles. This review indicated that nearly one-quarter of adults use a PPI. Of those using PPIs, 63% were less than 65 years. 56% of PPI users were female, and “White” ethnicities accounted for 75% of users. Nearly two-thirds of users were on high doses (≥ defined daily dose (DDD)), 25% of users continued PPIs for > 1 year, and 28% of these continued for > 3 years. Conclusion Given the widespread use PPIs and increasing concern regarding long-term use, this review provides a catalyst to support more rational use, particularly with unnecessary prolonged continuation. Clinicians should review PPI prescriptions regularly and deprescribe when there is no appropriate ongoing indication or evidence of benefit to reduce health harm and treatment cost.
Proton pump inhibitors (PPIs) reduce acid secretion in the stomach and rank as one of the most widely used acid-suppressing medicines globally. While PPIs are safe in the short-term, emerging evidence shows risks associated with long-term use. Current evidence on global PPI use is scarce. This systematic review aims to evaluate global PPI use in the general population.PURPOSEProton pump inhibitors (PPIs) reduce acid secretion in the stomach and rank as one of the most widely used acid-suppressing medicines globally. While PPIs are safe in the short-term, emerging evidence shows risks associated with long-term use. Current evidence on global PPI use is scarce. This systematic review aims to evaluate global PPI use in the general population.Ovid MEDLINE, Embase, and International Pharmaceutical Abstracts were systematically searched from inception to 31 March 2023 to identify observational studies on oral PPI use among individuals aged ≥ 18 years. PPI use was classified by demographics and medication factors (dose, duration, and PPI types). The absolute numbers of PPI users for each subcategory were summed and expressed as a percentage.METHODSOvid MEDLINE, Embase, and International Pharmaceutical Abstracts were systematically searched from inception to 31 March 2023 to identify observational studies on oral PPI use among individuals aged ≥ 18 years. PPI use was classified by demographics and medication factors (dose, duration, and PPI types). The absolute numbers of PPI users for each subcategory were summed and expressed as a percentage.The search identified data from 28 million PPI users in 23 countries from 65 articles. This review indicated that nearly one-quarter of adults use a PPI. Of those using PPIs, 63% were less than 65 years. 56% of PPI users were female, and "White" ethnicities accounted for 75% of users. Nearly two-thirds of users were on high doses (≥ defined daily dose (DDD)), 25% of users continued PPIs for > 1 year, and 28% of these continued for > 3 years.RESULTSThe search identified data from 28 million PPI users in 23 countries from 65 articles. This review indicated that nearly one-quarter of adults use a PPI. Of those using PPIs, 63% were less than 65 years. 56% of PPI users were female, and "White" ethnicities accounted for 75% of users. Nearly two-thirds of users were on high doses (≥ defined daily dose (DDD)), 25% of users continued PPIs for > 1 year, and 28% of these continued for > 3 years.Given the widespread use PPIs and increasing concern regarding long-term use, this review provides a catalyst to support more rational use, particularly with unnecessary prolonged continuation. Clinicians should review PPI prescriptions regularly and deprescribe when there is no appropriate ongoing indication or evidence of benefit to reduce health harm and treatment cost.CONCLUSIONGiven the widespread use PPIs and increasing concern regarding long-term use, this review provides a catalyst to support more rational use, particularly with unnecessary prolonged continuation. Clinicians should review PPI prescriptions regularly and deprescribe when there is no appropriate ongoing indication or evidence of benefit to reduce health harm and treatment cost.
PurposeProton pump inhibitors (PPIs) reduce acid secretion in the stomach and rank as one of the most widely used acid-suppressing medicines globally. While PPIs are safe in the short-term, emerging evidence shows risks associated with long-term use. Current evidence on global PPI use is scarce. This systematic review aims to evaluate global PPI use in the general population.MethodsOvid MEDLINE, Embase, and International Pharmaceutical Abstracts were systematically searched from inception to 31 March 2023 to identify observational studies on oral PPI use among individuals aged ≥ 18 years. PPI use was classified by demographics and medication factors (dose, duration, and PPI types). The absolute numbers of PPI users for each subcategory were summed and expressed as a percentage.ResultsThe search identified data from 28 million PPI users in 23 countries from 65 articles. This review indicated that nearly one-quarter of adults use a PPI. Of those using PPIs, 63% were less than 65 years. 56% of PPI users were female, and “White” ethnicities accounted for 75% of users. Nearly two-thirds of users were on high doses (≥ defined daily dose (DDD)), 25% of users continued PPIs for > 1 year, and 28% of these continued for > 3 years.ConclusionGiven the widespread use PPIs and increasing concern regarding long-term use, this review provides a catalyst to support more rational use, particularly with unnecessary prolonged continuation. Clinicians should review PPI prescriptions regularly and deprescribe when there is no appropriate ongoing indication or evidence of benefit to reduce health harm and treatment cost.
Proton pump inhibitors (PPIs) reduce acid secretion in the stomach and rank as one of the most widely used acid-suppressing medicines globally. While PPIs are safe in the short-term, emerging evidence shows risks associated with long-term use. Current evidence on global PPI use is scarce. This systematic review aims to evaluate global PPI use in the general population. Ovid MEDLINE, Embase, and International Pharmaceutical Abstracts were systematically searched from inception to 31 March 2023 to identify observational studies on oral PPI use among individuals aged ≥ 18 years. PPI use was classified by demographics and medication factors (dose, duration, and PPI types). The absolute numbers of PPI users for each subcategory were summed and expressed as a percentage. The search identified data from 28 million PPI users in 23 countries from 65 articles. This review indicated that nearly one-quarter of adults use a PPI. Of those using PPIs, 63% were less than 65 years. 56% of PPI users were female, and "White" ethnicities accounted for 75% of users. Nearly two-thirds of users were on high doses (≥ defined daily dose (DDD)), 25% of users continued PPIs for > 1 year, and 28% of these continued for > 3 years. Given the widespread use PPIs and increasing concern regarding long-term use, this review provides a catalyst to support more rational use, particularly with unnecessary prolonged continuation. Clinicians should review PPI prescriptions regularly and deprescribe when there is no appropriate ongoing indication or evidence of benefit to reduce health harm and treatment cost.
Author Braund, Rhiannon
Shanika, Lelwala Guruge Thushani
Reynolds, Andrew
Pattison, Sharon
Author_xml – sequence: 1
  givenname: Lelwala Guruge Thushani
  surname: Shanika
  fullname: Shanika, Lelwala Guruge Thushani
  organization: New Zealand Pharmacovigilance Centre, University of Otago, Department of Pharmacy and Pharmaceutical Science, University of Sri Jayewardenepura
– sequence: 2
  givenname: Andrew
  surname: Reynolds
  fullname: Reynolds, Andrew
  organization: Department of Medicine, Dunedin School of Medicine, University of Otago
– sequence: 3
  givenname: Sharon
  surname: Pattison
  fullname: Pattison, Sharon
  organization: Department of Medicine, Dunedin School of Medicine, University of Otago
– sequence: 4
  givenname: Rhiannon
  surname: Braund
  fullname: Braund, Rhiannon
  email: rhiannon.braund@otago.ac.nz
  organization: New Zealand Pharmacovigilance Centre, University of Otago
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37420019$$D View this record in MEDLINE/PubMed
BookMark eNp9kU9vFSEUxYmpsa_VL-DCkLhxM_UCw8zgxpjGP02btAtdE-DdeaWZgRFmatpPL89Xa-2iK0L4ncs59xyQvRADEvKawREDaN9nAM67CrioQEhRV7fPyIrVglcMarZHVgCCVY1qYZ8c5HwFwKQC8YLsi7bm5aZW5PQixTkGOi3jRH249NbPMdEl4weab_KMo5m9owmvPf6isaebIVoz0DlhWGdqwppOybjCYH5JnvdmyPjq7jwkP758_n78rTo7_3py_OmscnUr58q12KNirsO-E0whMttLJ6wF0zZOyrpG4MitlR1rtkEb5ZpeSNn0dWsbIQ7Jx93cabEjrh2GOZlBT8mPJt3oaLz-_yX4S72J17qshbdSyjLh3d2EFH8umGc9-uxwGEzAuGTNOyF5q5RsCvr2EXoVlxRKvkJJUKxWHRTqzUNL917-LroAfAe4FHNO2N8jDPQ2pN61qUub-k-b-raIukci5-fSR9zG8sPTUrGT5vJP2GD6Z_sJ1W_JL7S0
CitedBy_id crossref_primary_10_1186_s12913_024_12033_5
crossref_primary_10_1016_j_intimp_2025_114227
crossref_primary_10_1136_gutjnl_2024_332154
crossref_primary_10_1016_j_jocn_2025_111056
crossref_primary_10_3390_jcm13206187
crossref_primary_10_1007_s11096_024_01746_6
crossref_primary_10_1055_s_0044_1791827
crossref_primary_10_7759_cureus_63829
crossref_primary_10_1111_jgs_19326
crossref_primary_10_3389_fphar_2025_1523399
crossref_primary_10_1080_17425255_2024_2397433
crossref_primary_10_1128_cmr_00135_23
crossref_primary_10_1053_j_gastro_2024_06_038
crossref_primary_10_1007_s11894_024_00943_7
crossref_primary_10_7759_cureus_71446
crossref_primary_10_1155_2024_7747599
crossref_primary_10_1016_j_intimp_2024_113728
crossref_primary_10_1007_s40264_024_01502_9
crossref_primary_10_3390_biomedicines12010170
crossref_primary_10_1002_hsr2_70494
crossref_primary_10_1159_000538399
crossref_primary_10_1080_17576180_2024_2372162
crossref_primary_10_36290_vnl_2024_033
crossref_primary_10_1007_s00228_023_03564_7
crossref_primary_10_3390_ijms252312850
crossref_primary_10_1080_14796678_2024_2412910
crossref_primary_10_2174_0115672050289946240223050737
crossref_primary_10_1186_s12877_024_05185_w
crossref_primary_10_1016_j_foodres_2025_115833
crossref_primary_10_3390_children11030296
crossref_primary_10_1016_j_jsps_2023_101841
crossref_primary_10_1097_01_JAA_0000000000000152
crossref_primary_10_3390_ph16121722
crossref_primary_10_56782_pps_226
crossref_primary_10_3390_biomedicines12071414
crossref_primary_10_3390_healthcare13050442
crossref_primary_10_3961_jpmph_24_357
crossref_primary_10_1093_ehjcvp_pvae037
crossref_primary_10_7759_cureus_51067
crossref_primary_10_1155_jcpt_6643853
crossref_primary_10_1186_s13019_024_03161_4
crossref_primary_10_1080_14656566_2024_2416585
crossref_primary_10_1007_s00210_024_03206_4
crossref_primary_10_1080_02813432_2024_2321525
crossref_primary_10_3390_ijms25137286
crossref_primary_10_3389_fimmu_2024_1477993
crossref_primary_10_1136_spcare_2023_004542
crossref_primary_10_3390_jpm14050529
crossref_primary_10_1053_j_gastro_2024_09_020
crossref_primary_10_1681_ASN_0000000000000398
crossref_primary_10_1136_bmjopen_2024_094495
crossref_primary_10_1016_j_nurpra_2024_105159
crossref_primary_10_7759_cureus_64143
crossref_primary_10_1089_thy_2023_0382
crossref_primary_10_1016_j_ejps_2024_106781
crossref_primary_10_54393_pjhs_v5i10_1859
crossref_primary_10_7759_cureus_55035
crossref_primary_10_1016_j_ijid_2024_107273
crossref_primary_10_1016_j_jamda_2024_105393
crossref_primary_10_26416_Med_162_6_2024_10321
crossref_primary_10_1097_MEG_0000000000002788
crossref_primary_10_1186_s12909_024_06215_2
crossref_primary_10_1186_s12875_024_02351_2
crossref_primary_10_3390_ph17081082
crossref_primary_10_1016_j_heliyon_2024_e28566
crossref_primary_10_3897_pharmacia_72_e142999
crossref_primary_10_1016_j_jinf_2024_106202
crossref_primary_10_1177_20543581241312618
crossref_primary_10_5937_sanamed0_56268
crossref_primary_10_1136_flgastro_2024_102944
crossref_primary_10_1186_s12875_024_02459_5
crossref_primary_10_1080_14740338_2024_2387314
crossref_primary_10_7759_cureus_71418
crossref_primary_10_1038_s41598_024_83321_7
crossref_primary_10_1016_j_pec_2025_108654
crossref_primary_10_1001_jamainternmed_2024_4739
crossref_primary_10_1111_jgh_16694
Cites_doi 10.1002/pds.5352
10.1007/s00198-009-0891-4
10.1111/j.1365-2036.2008.03900.x
10.1016/j.ejim.2007.10.020
10.1111/apt.13450
10.1007/s11606-012-2211-5
10.25100/cm.v44i1.1028
10.1111/jgs.15073
10.1093/intqhc/mzw138
10.3748/wjg.v19.i2.258
10.2147/RMHP.S223118
10.1093/cid/cir767
10.1097/MJT.0000000000000154
10.1002/pds.1969
10.1177/1756283X16650156
10.1097/MCG.0b013e31818a386e
10.1002/pds.4043
10.1002/jppr.1548
10.1111/imj.12757
10.1007/s00223-014-9855-6
10.1177/1756284821998928
10.1111/apt.13568
10.1002/pds.4135
10.1046/j.1365-2036.1998.00374.x
10.1186/s12875-022-01941-2
10.1136/gutjnl-2020-323845
10.1038/ajg.2013.421
10.1007/s00228-021-03257-z
10.1681/ASN.2015121377
10.1001/jamaneurol.2015.4791
10.4212/cjhp.v71i5.2839
10.4212/cjhp.v71i5.2837
10.1007/s00228-014-1681-2
10.1111/1468-0009.12193
10.1111/jgs.14528
10.1002/jcph.805
10.1093/fampra/cmz025
10.1097/MJT.0b013e31829c4c71
10.1186/1472-6963-12-408
10.1016/j.jamda.2018.06.021
10.1111/j.1365-2036.2006.02982.x
10.1186/s12889-022-13217-6
10.1007/s10620-011-1589-y
10.1111/j.1445-5994.2010.02259.x
10.1097/MCG.0b013e3182151be7
10.1185/03007990903035745
10.1002/1099-1557(200009/10)9:5<383::AID-PDS506>3.0.CO;2-W
10.3390/jcm9113728
10.1016/j.jval.2018.04.560
10.5056/jnm18140
10.1016/j.canep.2018.02.004
10.1371/journal.pone.0124653
10.2165/00002018-200831040-00005
10.1136/gutjnl-2012-304269
10.1007/s00406-014-0554-0
10.1016/j.heliyon.2021.e07595
10.1111/jgs.16117
10.1007/s00228-019-02810-1
10.1016/j.atherosclerosis.2018.08.035
10.3399/BJGP.2022.0178
10.1111/dom.14176
10.1177/2042098617715381
10.1111/jcpt.12371
10.1046/j.1365-2125.2000.00262.x
10.1016/j.bone.2020.115502
10.1136/bmjn71
10.1080/03007995.2017.1308921
10.9778/cmajo.20140074
10.1177/1756284818777943
10.3389/fphar.2020.00607
10.4321/S1130-01082013000300003
10.1371/journal.pone.0168618
10.1007/s40801-019-0157-1
10.1177/1756284820913743
10.1016/j.japh.2020.09.015
10.1038/sj.bjc.6605024
10.4212/cjhp.v71i4.2828
ContentType Journal Article
Copyright The Author(s) 2023
2023. The Author(s).
The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2023
– notice: 2023. The Author(s).
– notice: The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7TK
7U9
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
H94
K9.
KB0
M0S
M1P
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
5PM
DOI 10.1007/s00228-023-03534-z
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Neurosciences Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Health & Medical Collection (Alumni)
Medical Database
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
ProQuest One Academic Middle East (New)
MEDLINE
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1432-1041
EndPage 1172
ExternalDocumentID PMC10427555
37420019
10_1007_s00228_023_03534_z
Genre Systematic Review
Journal Article
GrantInformation_xml – fundername: University of Otago
– fundername: ;
GroupedDBID ---
-4W
-56
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
.VR
04C
06C
06D
0R~
0VY
199
1N0
1SB
2.D
203
28-
29G
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
36B
3O-
3SX
3V.
4.4
406
408
409
40D
40E
53G
5QI
5RE
5VS
67N
67Z
6NX
6PF
78A
7RV
7X7
88E
8AO
8FI
8FJ
8FW
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAWTL
AAYIU
AAYOK
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABLJU
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFO
ACGFS
ACHSB
ACHVE
ACHXU
ACIHN
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACREN
ACZOJ
ADBBV
ADHHG
ADHIR
ADINQ
ADJJI
ADKNI
ADKPE
ADOJX
ADRFC
ADTPH
ADURQ
ADYFF
ADYOE
ADYPR
ADZKW
AEAQA
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFDYV
AFEXP
AFFNX
AFGCZ
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMTXH
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BKEYQ
BMSDO
BPHCQ
BSONS
BVXVI
C6C
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
ECT
EIHBH
EIOEI
EJD
EMB
EMOBN
EN4
EPAXT
ESBYG
EX3
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IMOTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAS
LLZTM
M1P
M4Y
MA-
MK0
N2Q
N9A
NAPCQ
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
P19
P2P
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RIG
RNI
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SBY
SCLPG
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
T16
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK6
WK8
WOW
Y6R
YLTOR
Z45
Z7U
Z7V
Z7W
Z81
Z82
Z83
Z87
Z8O
Z8P
Z8Q
Z8U
Z8V
Z8W
Z91
ZGI
ZMTXR
ZOVNA
ZXP
~EX
~KM
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACMFV
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
ABRTQ
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
7TK
7U9
7XB
8FK
H94
K9.
PKEHL
PQEST
PQUKI
7X8
5PM
ID FETCH-LOGICAL-c475t-c7efe91c8ef8319ee1bf5c3bb0a76c5544e02e2bb5816100769c6f3556f47b633
IEDL.DBID C6C
ISSN 0031-6970
1432-1041
IngestDate Thu Aug 21 18:40:34 EDT 2025
Fri Jul 11 06:31:37 EDT 2025
Sat Jul 26 02:15:52 EDT 2025
Mon Jul 21 05:57:42 EDT 2025
Tue Jul 01 01:41:24 EDT 2025
Thu Apr 24 23:11:41 EDT 2025
Fri Feb 21 02:43:43 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords Global use
Proton pump inhibitors
Systematic review
Dose
Long term
Language English
License 2023. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c475t-c7efe91c8ef8319ee1bf5c3bb0a76c5544e02e2bb5816100769c6f3556f47b633
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Undefined-1
ObjectType-Review-4
content type line 23
OpenAccessLink https://doi.org/10.1007/s00228-023-03534-z
PMID 37420019
PQID 2850914980
PQPubID 47171
PageCount 14
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_10427555
proquest_miscellaneous_2835279956
proquest_journals_2850914980
pubmed_primary_37420019
crossref_primary_10_1007_s00228_023_03534_z
crossref_citationtrail_10_1007_s00228_023_03534_z
springer_journals_10_1007_s00228_023_03534_z
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-09-01
PublicationDateYYYYMMDD 2023-09-01
PublicationDate_xml – month: 09
  year: 2023
  text: 2023-09-01
  day: 01
PublicationDecade 2020
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Germany
– name: Heidelberg
PublicationTitle European journal of clinical pharmacology
PublicationTitleAbbrev Eur J Clin Pharmacol
PublicationTitleAlternate Eur J Clin Pharmacol
PublicationYear 2023
Publisher Springer Berlin Heidelberg
Springer Nature B.V
Publisher_xml – name: Springer Berlin Heidelberg
– name: Springer Nature B.V
References Yap, Yip, Edwards, D'Intini, Tong (CR79) 2019; 49
Howden, Ballard, Koch, Gautille, Bagin (CR1) 2009; 43
Biyik, Solak, Ucar, Cifci, Tekis, Polat (CR17) 2017; 24
CR38
CR37
Muheim, Signorell, Markun, Chmiel, Neuner-Jehle, Blozik (CR57) 2021; 14
Martin, Lim, Kerry, Hilton (CR55) 1998; 12
Fattahi, Niknam, Shams, Anushiravani, Taghavi, Omrani (CR31) 2019; 12
Lassalle, Le Tri, Bardou, Biour, Kirchgesner, Rouby (CR48) 2019; 76
Nishtala, Soo (CR59) 2015; 45
Ma, Gervais, Lanouette (CR50) 2008; 43
Maes, Fixen, Linnebur (CR87) 2017; 8
Farrell, Pottie, Thompson, Boghossian, Pizzola, Rashid (CR94) 2017; 63
Claessens, Heerdink, Van Eijk, Lamers, Leufkens (CR24) 2000; 9
Mafi, May, Kahn, Chong, Corona, Yang (CR52) 2019; 67
Van Boxel, Hagenaars, Smout, Siersema (CR73) 2009; 29
Gadzhanova, Roughead, Mackson (CR32) 2010; 42
Larsen, Schou, Kristiansen, Hallas (CR47) 2014; 70
Wallerstedt, Fastbom, Linke, Vitols (CR75) 2017; 26
Gendre, Mocquard, Artarit, Chaslerie, Caillet, Huon (CR33) 2022; 23
Sarzynski, Puttarajappa, Xie, Grover, Laird-Fick (CR67) 2011; 56
Guillot, Maumus-Robert, Marceron, Noize, Pariente, Bezin (CR85) 2020; 9
Chan, Liang, Tung, Kinkade, Tejani (CR21) 2018; 71
Hong, Kang, Choi, Kim, Seo, Lee (CR40) 2013; 19
CR58
CR53
Casula, Scotti, Galimberti, Mozzanica, Tragni, Corrao (CR20) 2018; 277
Hu, You, Sun, Lv, Wu, Liu (CR4) 2018; 21
Doell, Walus, To, Bell (CR30) 2018; 71
CR66
CR63
Chey, Mody, Wu, Chen, Kothari, Persson (CR23) 2009; 25
Sheikh, Waghray, Waghray, Dong, Wolfe (CR71) 2014; 109
Dills, Shah, Messinger-Rapport, Bradford, Syed (CR96) 2018; 19
Pasina, Urru, Mandelli, Giua, Minghetti (CR61) 2016; 41
Martin, Dunn, Freemantle, Shakir (CR54) 2000; 50
Rückert-Eheberg, Nolde, Ahn, Tauscher, Gerlach, Güntner (CR65) 2022; 78
Clooney, Bernstein, Leslie, Vagianos, Sargent, Laserna-Mendieta (CR25) 2016; 43
Schneider, Kolitsopoulos, Corley (CR68) 2016; 43
Pottegård, Broe, Hallas, de Muckadell, Lassen, Lødrup (CR62) 2016; 9
Brusselaers, Engstrand, Lagergren (CR18) 2018; 53
CR77
CR76
Davies, Wilton, Shakir (CR27) 2012; 31
El-Serag, Sweet, Winchester, Dent (CR90) 2014; 63
Ntaios, Chatzinikolaou, Kaiafa, Savopoulos, Hatzitolios, Karamitsos (CR5) 2009; 20
Gray, Walker, Dublin, Yu, Aiello Bowles, Anderson (CR35) 2018; 66
Reynolds, Diep Pham, Montez, Mann (CR13) 2020; 22
Van Soest, Siersema, Dieleman, Sturkenboom, Kuipers (CR74) 2006; 24
CR2
Machado-Alba, Fernández, Castrillón, Campo, Echeverri, Gaviria (CR51) 2013; 44
CR3
CR6
Haenisch, von Holt, Wiese, Prokein, Lange, Ernst (CR36) 2014; 265
CR8
CR7
CR9
Ding, Heller, Ahern, Brown (CR29) 2014; 94
Torres-Bondia, de Batlle, Galván, Buti, Barbé, Piñol-Ripoll (CR72) 2022; 22
CR89
CR88
Hermos, Young, Fonda, Gagnon, Fiore, Lawler (CR39) 2012; 54
Hughes, Tanpurekul, Keen, Ee (CR41) 2009; 17
CR81
CR80
Xie, Bowe, Li, Xian, Balasubramanian, Al-Aly (CR78) 2016; 27
Hollingworth, Duncan, Martin (CR97) 2010; 19
Seo, Park, You, Kim, Lee, Kim (CR69) 2021; 70
CR16
CR15
CR14
CR12
Gomm, von Holt, Thomé, Broich, Maier, Fink (CR34) 2016; 73
CR11
CR10
Moriarty, Bennett, Cahir, Fahey (CR56) 2016; 64
Pratt, Kalisch Ellett, Sluggett, Gadzhanova, Ramsay, Kerr (CR86) 2016; 29
CR95
Kojima, Takeuchi, Sanomura, Higashino, Kojima, Fukumoto (CR46) 2018; 97
CR92
Rababa, Rababa'h (CR84) 2021; 7
CR91
Koggel, Lantinga, Büchner, Drenth, Frankema, Heeregrave (CR45) 2022; 72
Jarbøl, Lykkegaard, Hansen, Munck, Haastrup (CR42) 2019; 36
Othman, Card, Crooks (CR60) 2016; 25
Cahir, Fahey, Tilson, Teljeur, Bennett (CR19) 2012; 12
Shah, LePendu, Bauer-Mehren, Ghebremariam, Iyer, Marcus (CR70) 2015; 10
Yamasaki, Hemond, Eisa, Ganocy, Fass (CR82) 2018; 24
Rosenberg, Tzadok, Chodick, Kariv (CR64) 2021; 30
Kim, Lee, Park, Shim, Lee, Park (CR44) 2015; 22
CR26
Morini, Zullo, Oliveti, Chiriatti, Marmo, Chiuri (CR83) 2011; 45
CR22
Jena, Sun, Goldman (CR43) 2012; 28
Lee, Mark, Celi, Danziger (CR49) 2016; 56
Cohn (CR93) 2016; 94
de Vries, Cooper, Cockle, van Staa, Cooper (CR28) 2009; 20
WD Chey (3534_CR23) 2009; 25
T Yamasaki (3534_CR82) 2018; 24
RM Martin (3534_CR55) 1998; 12
3534_CR81
PS Nishtala (3534_CR59) 2015; 45
3534_CR80
3534_CR89
L Pasina (3534_CR61) 2016; 41
B Haenisch (3534_CR36) 2014; 265
3534_CR88
AAMC Claessens (3534_CR24) 2000; 9
B Farrell (3534_CR94) 2017; 63
JA Hermos (3534_CR39) 2012; 54
3534_CR2
J Lee (3534_CR49) 2016; 56
3534_CR9
3534_CR7
3534_CR8
G Ntaios (3534_CR5) 2009; 20
3534_CR6
M Casula (3534_CR20) 2018; 277
3534_CR3
3534_CR76
M Davies (3534_CR27) 2012; 31
3534_CR77
NL Pratt (3534_CR86) 2016; 29
AN Reynolds (3534_CR13) 2020; 22
M Biyik (3534_CR17) 2017; 24
AG Clooney (3534_CR25) 2016; 43
SL Gray (3534_CR35) 2018; 66
KS Hong (3534_CR40) 2013; 19
3534_CR26
3534_CR22
ML Maes (3534_CR87) 2017; 8
F Torres-Bondia (3534_CR72) 2022; 22
3534_CR16
DE Jarbøl (3534_CR42) 2019; 36
L Muheim (3534_CR57) 2021; 14
C Cahir (3534_CR19) 2012; 12
3534_CR92
F de Vries (3534_CR28) 2009; 20
3534_CR95
3534_CR91
3534_CR12
3534_CR14
3534_CR15
3534_CR10
3534_CR11
J Ding (3534_CR29) 2014; 94
X Hu (3534_CR4) 2018; 21
HB El-Serag (3534_CR90) 2014; 63
SI Seo (3534_CR69) 2021; 70
M Rababa (3534_CR84) 2021; 7
J Machado-Alba (3534_CR51) 2013; 44
SV Gadzhanova (3534_CR32) 2010; 42
F Othman (3534_CR60) 2016; 25
V Rosenberg (3534_CR64) 2021; 30
A Doell (3534_CR30) 2018; 71
A Chan (3534_CR21) 2018; 71
OS Van Boxel (3534_CR73) 2009; 29
RM Martin (3534_CR54) 2000; 50
3534_CR38
JL Schneider (3534_CR68) 2016; 43
M Lassalle (3534_CR48) 2019; 76
AB Jena (3534_CR43) 2012; 28
S Kim (3534_CR44) 2015; 22
MH Yap (3534_CR79) 2019; 49
S Hollingworth (3534_CR97) 2010; 19
MR Fattahi (3534_CR31) 2019; 12
J Cohn (3534_CR93) 2016; 94
JN Mafi (3534_CR52) 2019; 67
Y Xie (3534_CR78) 2016; 27
LM Koggel (3534_CR45) 2022; 72
3534_CR37
MD Larsen (3534_CR47) 2014; 70
IM Rückert-Eheberg (3534_CR65) 2022; 78
CW Howden (3534_CR1) 2009; 43
JD Hughes (3534_CR41) 2009; 17
J Guillot (3534_CR85) 2020; 9
P Gendre (3534_CR33) 2022; 23
E Sarzynski (3534_CR67) 2011; 56
I Sheikh (3534_CR71) 2014; 109
A Pottegård (3534_CR62) 2016; 9
Y Kojima (3534_CR46) 2018; 97
3534_CR63
N Brusselaers (3534_CR18) 2018; 53
3534_CR66
S Morini (3534_CR83) 2011; 45
W Gomm (3534_CR34) 2016; 73
SM Wallerstedt (3534_CR75) 2017; 26
EM Van Soest (3534_CR74) 2006; 24
F Moriarty (3534_CR56) 2016; 64
H Dills (3534_CR96) 2018; 19
J Ma (3534_CR50) 2008; 43
3534_CR58
NH Shah (3534_CR70) 2015; 10
3534_CR53
37725121 - Eur J Clin Pharmacol. 2023 Nov;79(11):1579-1581. doi: 10.1007/s00228-023-03564-7.
References_xml – ident: CR22
– ident: CR16
– volume: 30
  start-page: 1576
  issue: 11
  year: 2021
  end-page: 1587
  ident: CR64
  article-title: Proton pump inhibitors long term use-trends and patterns over 15 years of a large health maintenance organization
  publication-title: Pharmacoepidemiol Drug Saf
  doi: 10.1002/pds.5352
– volume: 20
  start-page: 1989
  issue: 12
  year: 2009
  end-page: 1998
  ident: CR28
  article-title: Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-009-0891-4
– volume: 29
  start-page: 571
  issue: 5
  year: 2009
  end-page: 579
  ident: CR73
  article-title: Socio-demographic factors influence chronic proton pump inhibitor use by a large population in the Netherlands
  publication-title: Aliment Pharmacol Ther
  doi: 10.1111/j.1365-2036.2008.03900.x
– ident: CR80
– volume: 20
  start-page: 171
  issue: 2
  year: 2009
  end-page: 173
  ident: CR5
  article-title: Evaluation of use of proton pump inhibitors in Greece
  publication-title: Eur J Intern Med
  doi: 10.1016/j.ejim.2007.10.020
– ident: CR77
– ident: CR8
– volume: 43
  start-page: 73
  issue: 1
  year: 2016
  end-page: 82
  ident: CR68
  article-title: Risk of gastric cancer, gastrointestinal cancers and other cancers: a comparison of treatment with pantoprazole and other proton pump inhibitors
  publication-title: Aliment Pharmacol Ther
  doi: 10.1111/apt.13450
– volume: 28
  start-page: 223
  issue: 2
  year: 2012
  end-page: 230
  ident: CR43
  article-title: Confounding in the association of proton pump inhibitor use with risk of community-acquired pneumonia
  publication-title: Journal of general internal medicine : JGIM
  doi: 10.1007/s11606-012-2211-5
– volume: 44
  start-page: 13
  issue: 1
  year: 2013
  end-page: 18
  ident: CR51
  article-title: Prescribing patterns and economic costs of proton pump inhibitors in Colombia
  publication-title: Colomb Med (Cali)
  doi: 10.25100/cm.v44i1.1028
– volume: 66
  start-page: 247
  issue: 2
  year: 2018
  end-page: 253
  ident: CR35
  article-title: Proton pump inhibitor use and dementia risk: prospective population-based study
  publication-title: Journal of the American Geriatrics Society (JAGS)
  doi: 10.1111/jgs.15073
– volume: 29
  start-page: 75
  issue: 1
  year: 2016
  end-page: 82
  ident: CR86
  article-title: Use of proton pump inhibitors among older Australians: national quality improvement programmes have led to sustained practice change
  publication-title: Int J Qual Health Care
  doi: 10.1093/intqhc/mzw138
– volume: 19
  start-page: 258
  issue: 2
  year: 2013
  end-page: 264
  ident: CR40
  article-title: Gastrointestinal tuberculosis is not associated with proton pump inhibitors: a retrospective cohort study
  publication-title: World J Gastroenterol: WJG
  doi: 10.3748/wjg.v19.i2.258
– ident: CR92
– ident: CR88
– volume: 12
  start-page: 349
  year: 2019
  end-page: 355
  ident: CR31
  article-title: The association between prolonged proton pump inhibitors use and bone mineral density
  publication-title: Risk management and healthcare policy
  doi: 10.2147/RMHP.S223118
– ident: CR11
– volume: 54
  start-page: 33
  issue: 1
  year: 2012
  end-page: 42
  ident: CR39
  article-title: Risk of community-acquired pneumonia in veteran patients to whom proton pump inhibitors were dispensed
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/cir767
– volume: 24
  start-page: e52
  issue: 1
  year: 2017
  end-page: e55
  ident: CR17
  article-title: Hypomagnesemia among outpatient long-term proton pump inhibitor users
  publication-title: Am J Ther
  doi: 10.1097/MJT.0000000000000154
– volume: 19
  start-page: 1019
  issue: 10
  year: 2010
  end-page: 1024
  ident: CR97
  article-title: Marked increase in proton pump inhibitors use in Australia
  publication-title: Pharmacoepidemiol Drug Saf
  doi: 10.1002/pds.1969
– volume: 9
  start-page: 671
  issue: 5
  year: 2016
  end-page: 678
  ident: CR62
  article-title: Use of proton-pump inhibitors among adults: a Danish nationwide drug utilization study
  publication-title: Ther Adv Gastroenterol
  doi: 10.1177/1756283X16650156
– volume: 43
  start-page: 323
  issue: 4
  year: 2009
  end-page: 326
  ident: CR1
  article-title: Control of 24-hour intragastric acidity with morning dosing of immediate-release and delayed-release proton pump inhibitors in patients with GERD
  publication-title: J Clin Gastroenterol
  doi: 10.1097/MCG.0b013e31818a386e
– volume: 25
  start-page: 1079
  issue: 9
  year: 2016
  end-page: 1087
  ident: CR60
  article-title: Proton pump inhibitor prescribing patterns in the UK: a primary care database study: proton pump inhibitor prescription in the UK
  publication-title: Pharmacoepidemiol Drug Saf
  doi: 10.1002/pds.4043
– volume: 49
  start-page: 447
  issue: 5
  year: 2019
  end-page: 453
  ident: CR79
  article-title: Appropriateness of proton pump inhibitor use in patients admitted under the general medical unit
  publication-title: J Pharm Pract Res
  doi: 10.1002/jppr.1548
– volume: 45
  start-page: 624
  issue: 6
  year: 2015
  end-page: 629
  ident: CR59
  article-title: Proton pump inhibitors utilisation in older people in New Zealand from 2005 to 2013: proton pump inhibitor utilisation
  publication-title: Intern Med J
  doi: 10.1111/imj.12757
– ident: CR66
– ident: CR91
– volume: 63
  start-page: 354
  issue: 5
  year: 2017
  end-page: 364
  ident: CR94
  article-title: Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline
  publication-title: Can Fam Physician
– volume: 94
  start-page: 597
  issue: 6
  year: 2014
  end-page: 607
  ident: CR29
  article-title: The relationship between proton pump inhibitor adherence and fracture risk in the elderly
  publication-title: Calcif Tissue Int
  doi: 10.1007/s00223-014-9855-6
– ident: CR89
– volume: 14
  start-page: 1756284821998928
  year: 2021
  ident: CR57
  article-title: Potentially inappropriate proton-pump inhibitor prescription in the general population: a claims-based retrospective time trend analysis
  publication-title: Therap Adv Gastroenterol
  doi: 10.1177/1756284821998928
– volume: 43
  start-page: 974
  issue: 9
  year: 2016
  end-page: 984
  ident: CR25
  article-title: A comparison of the gut microbiome between long-term users and non-users of proton pump inhibitors
  publication-title: Aliment Pharmacol Ther
  doi: 10.1111/apt.13568
– ident: CR10
– volume: 26
  start-page: 9
  issue: 1
  year: 2017
  end-page: 16
  ident: CR75
  article-title: Long-term use of proton pump inhibitors and prevalence of disease- and drug-related reasons for gastroprotection—a cross-sectional population-based study
  publication-title: Pharmacoepidemiol Drug Saf
  doi: 10.1002/pds.4135
– ident: CR6
– volume: 12
  start-page: 797
  issue: 8
  year: 1998
  end-page: 805
  ident: CR55
  article-title: Trends in prescribing H2-receptor antagonists and proton pump inhibitors in primary care
  publication-title: Aliment Pharmacol Ther
  doi: 10.1046/j.1365-2036.1998.00374.x
– volume: 23
  start-page: 341
  issue: 1
  year: 2022
  ident: CR33
  article-title: (De)Prescribing of proton pump inhibitors: what has changed in recent years? an observational regional study from the French health insurance database
  publication-title: BMC Prim Care
  doi: 10.1186/s12875-022-01941-2
– ident: CR63
– volume: 70
  start-page: 2066
  issue: 11
  year: 2021
  end-page: 2075
  ident: CR69
  article-title: Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea
  publication-title: Gut
  doi: 10.1136/gutjnl-2020-323845
– volume: 109
  start-page: 789
  issue: 6
  year: 2014
  end-page: 794
  ident: CR71
  article-title: Consumer use of over-the-counter proton pump inhibitors in patients with gastroesophageal reflux disease
  publication-title: Am J Gastroenterol
  doi: 10.1038/ajg.2013.421
– volume: 78
  start-page: 657
  issue: 4
  year: 2022
  end-page: 667
  ident: CR65
  article-title: Who gets prescriptions for proton pump inhibitors and why? A drug-utilization study with claims data in Bavaria, Germany, 2010–2018
  publication-title: Eur J Clin Pharmacol
  doi: 10.1007/s00228-021-03257-z
– ident: CR3
– ident: CR38
– volume: 27
  start-page: 3153
  issue: 10
  year: 2016
  end-page: 3163
  ident: CR78
  article-title: Proton pump inhibitors and risk of incident CKD and progression to ESRD
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2015121377
– volume: 17
  start-page: 15
  issue: 1
  year: 2009
  end-page: 21
  ident: CR41
  article-title: Reducing the cost of proton pump inhibitors by adopting best practice
  publication-title: Qual Prim Care
– volume: 73
  start-page: 410
  issue: 4
  year: 2016
  end-page: 416
  ident: CR34
  article-title: Association of proton pump inhibitors with risk of dementia: a pharmacoepidemiological claims data analysis
  publication-title: JAMA Neurol
  doi: 10.1001/jamaneurol.2015.4791
– volume: 71
  start-page: 302
  issue: 5
  year: 2018
  end-page: 307
  ident: CR30
  article-title: Quantifying candidacy for deprescribing of proton pump inhibitors among long-term care residents
  publication-title: Canadian journal of hospital pharmacy
  doi: 10.4212/cjhp.v71i5.2839
– volume: 71
  start-page: 295
  issue: 5
  year: 2018
  end-page: 301
  ident: CR21
  article-title: Is there a reason for the proton pump inhibitor? An assessment of prescribing for residential care patients in British Columbia
  publication-title: Canadian journal of hospital pharmacy
  doi: 10.4212/cjhp.v71i5.2837
– volume: 70
  start-page: 859
  issue: 7
  year: 2014
  end-page: 865
  ident: CR47
  article-title: The influence of hospital drug formulary policies on the prescribing patterns of proton pump inhibitors in primary care
  publication-title: Eur J Clin Pharmacol
  doi: 10.1007/s00228-014-1681-2
– volume: 94
  start-page: 260
  issue: 2
  year: 2016
  end-page: 263
  ident: CR93
  article-title: The drug price controversy nobody notices
  publication-title: Milbank Q.
  doi: 10.1111/1468-0009.12193
– ident: CR12
– volume: 64
  start-page: e291
  issue: 12
  year: 2016
  end-page: e296
  ident: CR56
  article-title: Characterizing potentially inappropriate prescribing of proton pump inhibitors in older people in primary care in Ireland from 1997 to 2012
  publication-title: Journal of the American Geriatrics Society (JAGS)
  doi: 10.1111/jgs.14528
– volume: 56
  start-page: 1500
  issue: 12
  year: 2016
  end-page: 1506
  ident: CR49
  article-title: Proton pump inhibitors are not associated with acute kidney injury in critical illness
  publication-title: J Clin Pharmacol
  doi: 10.1002/jcph.805
– volume: 36
  start-page: 758
  issue: 6
  year: 2019
  end-page: 764
  ident: CR42
  article-title: Prescribing of proton-pump inhibitors: auditing the management and reasons for prescribing in Danish general practice
  publication-title: Fam Pract
  doi: 10.1093/fampra/cmz025
– volume: 22
  start-page: 14
  issue: 1
  year: 2015
  end-page: 21
  ident: CR44
  article-title: Clinical predictors associated with proton pump inhibitor-induced hypomagnesemia
  publication-title: Am J Ther
  doi: 10.1097/MJT.0b013e31829c4c71
– volume: 12
  start-page: 1
  issue: 1
  year: 2012
  end-page: 8
  ident: CR19
  article-title: Proton pump inhibitors: potential cost reductions by applying prescribing guidelines
  publication-title: BMC Health Serv Res
  doi: 10.1186/1472-6963-12-408
– volume: 43
  start-page: 436
  issue: 12
  year: 2008
  ident: CR50
  article-title: Preferential listing of a PPI: compliance with policy in a Canadian military population
  publication-title: Formulary (Cleveland, Ohio)
– ident: CR58
– volume: 19
  start-page: 923
  issue: 11
  year: 2018
  end-page: 935.e2
  ident: CR96
  article-title: Deprescribing medications for chronic diseases management in primary care settings: a systematic review of randomized controlled trials
  publication-title: J Am Med Dir Assoc
  doi: 10.1016/j.jamda.2018.06.021
– ident: CR15
– volume: 24
  start-page: 377
  issue: 2
  year: 2006
  end-page: 385
  ident: CR74
  article-title: Persistence and adherence to proton pump inhibitors in daily clinical practice
  publication-title: Aliment Pharmacol Ther
  doi: 10.1111/j.1365-2036.2006.02982.x
– ident: CR9
– ident: CR81
– volume: 22
  start-page: 818
  issue: 1
  year: 2022
  ident: CR72
  article-title: Evolution of the consumption trend of proton pump inhibitors in the Lleida Health Region between 2002 and 2015
  publication-title: BMC Public Health
  doi: 10.1186/s12889-022-13217-6
– ident: CR26
– volume: 56
  start-page: 2349
  issue: 8
  year: 2011
  end-page: 2353
  ident: CR67
  article-title: Association between proton pump inhibitor use and anemia: a retrospective cohort study
  publication-title: Dig Dis Sci
  doi: 10.1007/s10620-011-1589-y
– volume: 42
  start-page: e68
  issue: 5
  year: 2010
  end-page: e73
  ident: CR32
  article-title: Initiation and duration of proton pump inhibitors in the Australian veteran population
  publication-title: Intern Med J
  doi: 10.1111/j.1445-5994.2010.02259.x
– volume: 97
  start-page: 70
  issue: 1
  year: 2018
  end-page: 75
  ident: CR46
  article-title: Does the novel potassium-competitive acid blocker vonoprazan cause more hypergastrinemia than conventional proton pump inhibitors?
  publication-title: A multicenter prospective cross-sectional study Digestion
– volume: 45
  start-page: 780
  issue: 9
  year: 2011
  end-page: 784
  ident: CR83
  article-title: A very high rate of inappropriate use of gastroprotection for nonsteroidal anti-inflammatory drug therapy in primary care: a cross-sectional study
  publication-title: J Clin Gastroenterol
  doi: 10.1097/MCG.0b013e3182151be7
– ident: CR95
– volume: 25
  start-page: 1869
  issue: 8
  year: 2009
  end-page: 1878
  ident: CR23
  article-title: Treatment patterns and symptom control in patients with GERD: US community-based survey
  publication-title: Curr Med Res Opin
  doi: 10.1185/03007990903035745
– ident: CR14
– volume: 9
  start-page: 383
  issue: 5
  year: 2000
  end-page: 391
  ident: CR24
  article-title: Safety review in 10,008 users of lansoprazole in daily practice
  publication-title: Pharmacoepidemiol Drug Saf
  doi: 10.1002/1099-1557(200009/10)9:5<383::AID-PDS506>3.0.CO;2-W
– volume: 9
  start-page: 3728
  issue: 11
  year: 2020
  ident: CR85
  article-title: The burden of potentially inappropriate medications in chronic polypharmacy
  publication-title: J Clin Med
  doi: 10.3390/jcm9113728
– ident: CR2
– ident: CR37
– ident: CR53
– volume: 21
  start-page: S82
  year: 2018
  end-page: S83
  ident: CR4
  article-title: Off label use of proton pump inhibitors and economic burden in Chinese population: a retrospective analysis using claims database
  publication-title: Value in Health
  doi: 10.1016/j.jval.2018.04.560
– volume: 24
  start-page: 559
  issue: 4
  year: 2018
  end-page: 569
  ident: CR82
  article-title: The changing epidemiology of gastroesophageal reflux disease: are patients getting younger?
  publication-title: J Neurogastroenterol Motil
  doi: 10.5056/jnm18140
– volume: 53
  start-page: 172
  year: 2018
  end-page: 177
  ident: CR18
  article-title: Maintenance proton pump inhibition therapy and risk of oesophageal cancer
  publication-title: Cancer Epidemiol
  doi: 10.1016/j.canep.2018.02.004
– volume: 10
  issue: 6
  year: 2015
  ident: CR70
  article-title: Proton pump inhibitor usage and the risk of myocardial infarction in the general population
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0124653
– volume: 31
  start-page: 313
  issue: 4
  year: 2012
  end-page: 323
  ident: CR27
  article-title: Safety profile of esomeprazole: results of a prescription-event monitoring study of 11 595 patients in England
  publication-title: Drug Saf
  doi: 10.2165/00002018-200831040-00005
– volume: 63
  start-page: 871
  issue: 6
  year: 2014
  end-page: 880
  ident: CR90
  article-title: Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review
  publication-title: Gut
  doi: 10.1136/gutjnl-2012-304269
– volume: 265
  start-page: 419
  issue: 5
  year: 2014
  end-page: 428
  ident: CR36
  article-title: Risk of dementia in elderly patients with the use of proton pump inhibitors
  publication-title: Eur Arch Psychiatry Clin Neurosci
  doi: 10.1007/s00406-014-0554-0
– volume: 7
  issue: 7
  year: 2021
  ident: CR84
  article-title: The inappropriate use of proton pump inhibitors and its associated factors among community-dwelling older adults
  publication-title: Heliyon
  doi: 10.1016/j.heliyon.2021.e07595
– volume: 67
  start-page: 2600
  issue: 12
  year: 2019
  end-page: 2604
  ident: CR52
  article-title: Low-value proton pump inhibitor prescriptions among older adults at a large academic health system: harmful proton pump inhibitors in older adults
  publication-title: Journal of the American Geriatrics Society (JAGS)
  doi: 10.1111/jgs.16117
– volume: 76
  start-page: 449
  issue: 3
  year: 2019
  end-page: 457
  ident: CR48
  article-title: Use of proton pump inhibitors in adults in France: a nationwide drug utilization study
  publication-title: Eur J Clin Pharmacol
  doi: 10.1007/s00228-019-02810-1
– volume: 277
  start-page: 123
  year: 2018
  end-page: 129
  ident: CR20
  article-title: Use of proton pump inhibitors and risk of ischemic events in the general population
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2018.08.035
– volume: 72
  start-page: e899
  issue: 725
  year: 2022
  end-page: e906
  ident: CR45
  article-title: Predictors for inappropriate proton pump inhibitor use: observational study in primary care
  publication-title: Br J Gen Pract
  doi: 10.3399/BJGP.2022.0178
– volume: 22
  start-page: 2460
  issue: 12
  year: 2020
  end-page: 2467
  ident: CR13
  article-title: Dietary fibre intake in childhood or adolescence and subsequent health outcomes: a systematic review of prospective observational studies
  publication-title: Diabetes Obes Metab
  doi: 10.1111/dom.14176
– volume: 8
  start-page: 273
  issue: 9
  year: 2017
  end-page: 297
  ident: CR87
  article-title: Adverse effects of proton-pump inhibitor use in older adults: a review of the evidence
  publication-title: Ther Adv Drug Saf.
  doi: 10.1177/2042098617715381
– volume: 41
  start-page: 220
  issue: 2
  year: 2016
  end-page: 223
  ident: CR61
  article-title: Evidence-based and unlicensed indications for proton pump inhibitors and patients' preferences for discontinuation: a pilot study in a sample of Italian community pharmacies
  publication-title: J Clin Pharm Ther
  doi: 10.1111/jcpt.12371
– volume: 50
  start-page: 366
  issue: 4
  year: 2000
  end-page: 372
  ident: CR54
  article-title: The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies
  publication-title: Br J Clin Pharmacol
  doi: 10.1046/j.1365-2125.2000.00262.x
– ident: CR7
– ident: CR76
– volume: 56
  start-page: 1500
  issue: 12
  year: 2016
  ident: 3534_CR49
  publication-title: J Clin Pharmacol
  doi: 10.1002/jcph.805
– ident: 3534_CR95
– volume: 78
  start-page: 657
  issue: 4
  year: 2022
  ident: 3534_CR65
  publication-title: Eur J Clin Pharmacol
  doi: 10.1007/s00228-021-03257-z
– ident: 3534_CR77
  doi: 10.1016/j.bone.2020.115502
– volume: 277
  start-page: 123
  year: 2018
  ident: 3534_CR20
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2018.08.035
– volume: 29
  start-page: 75
  issue: 1
  year: 2016
  ident: 3534_CR86
  publication-title: Int J Qual Health Care
  doi: 10.1093/intqhc/mzw138
– volume: 53
  start-page: 172
  year: 2018
  ident: 3534_CR18
  publication-title: Cancer Epidemiol
  doi: 10.1016/j.canep.2018.02.004
– volume: 22
  start-page: 14
  issue: 1
  year: 2015
  ident: 3534_CR44
  publication-title: Am J Ther
  doi: 10.1097/MJT.0b013e31829c4c71
– volume: 45
  start-page: 780
  issue: 9
  year: 2011
  ident: 3534_CR83
  publication-title: J Clin Gastroenterol
  doi: 10.1097/MCG.0b013e3182151be7
– volume: 19
  start-page: 923
  issue: 11
  year: 2018
  ident: 3534_CR96
  publication-title: J Am Med Dir Assoc
  doi: 10.1016/j.jamda.2018.06.021
– volume: 19
  start-page: 1019
  issue: 10
  year: 2010
  ident: 3534_CR97
  publication-title: Pharmacoepidemiol Drug Saf
  doi: 10.1002/pds.1969
– volume: 71
  start-page: 295
  issue: 5
  year: 2018
  ident: 3534_CR21
  publication-title: Canadian journal of hospital pharmacy
  doi: 10.4212/cjhp.v71i5.2837
– volume: 28
  start-page: 223
  issue: 2
  year: 2012
  ident: 3534_CR43
  publication-title: Journal of general internal medicine : JGIM
  doi: 10.1007/s11606-012-2211-5
– volume: 45
  start-page: 624
  issue: 6
  year: 2015
  ident: 3534_CR59
  publication-title: Intern Med J
  doi: 10.1111/imj.12757
– volume: 19
  start-page: 258
  issue: 2
  year: 2013
  ident: 3534_CR40
  publication-title: World J Gastroenterol: WJG
  doi: 10.3748/wjg.v19.i2.258
– ident: 3534_CR11
  doi: 10.1136/bmjn71
– volume: 97
  start-page: 70
  issue: 1
  year: 2018
  ident: 3534_CR46
  publication-title: A multicenter prospective cross-sectional study Digestion
– ident: 3534_CR53
  doi: 10.1080/03007995.2017.1308921
– volume: 72
  start-page: e899
  issue: 725
  year: 2022
  ident: 3534_CR45
  publication-title: Br J Gen Pract
  doi: 10.3399/BJGP.2022.0178
– volume: 29
  start-page: 571
  issue: 5
  year: 2009
  ident: 3534_CR73
  publication-title: Aliment Pharmacol Ther
  doi: 10.1111/j.1365-2036.2008.03900.x
– ident: 3534_CR16
  doi: 10.9778/cmajo.20140074
– ident: 3534_CR14
– ident: 3534_CR37
  doi: 10.1177/1756284818777943
– volume: 44
  start-page: 13
  issue: 1
  year: 2013
  ident: 3534_CR51
  publication-title: Colomb Med (Cali)
  doi: 10.25100/cm.v44i1.1028
– volume: 9
  start-page: 383
  issue: 5
  year: 2000
  ident: 3534_CR24
  publication-title: Pharmacoepidemiol Drug Saf
  doi: 10.1002/1099-1557(200009/10)9:5<383::AID-PDS506>3.0.CO;2-W
– volume: 265
  start-page: 419
  issue: 5
  year: 2014
  ident: 3534_CR36
  publication-title: Eur Arch Psychiatry Clin Neurosci
  doi: 10.1007/s00406-014-0554-0
– ident: 3534_CR76
  doi: 10.3389/fphar.2020.00607
– volume: 22
  start-page: 2460
  issue: 12
  year: 2020
  ident: 3534_CR13
  publication-title: Diabetes Obes Metab
  doi: 10.1111/dom.14176
– ident: 3534_CR66
  doi: 10.4321/S1130-01082013000300003
– volume: 25
  start-page: 1869
  issue: 8
  year: 2009
  ident: 3534_CR23
  publication-title: Curr Med Res Opin
  doi: 10.1185/03007990903035745
– ident: 3534_CR7
– ident: 3534_CR22
  doi: 10.1371/journal.pone.0168618
– volume: 9
  start-page: 671
  issue: 5
  year: 2016
  ident: 3534_CR62
  publication-title: Ther Adv Gastroenterol
  doi: 10.1177/1756283X16650156
– ident: 3534_CR81
– volume: 43
  start-page: 974
  issue: 9
  year: 2016
  ident: 3534_CR25
  publication-title: Aliment Pharmacol Ther
  doi: 10.1111/apt.13568
– ident: 3534_CR2
– volume: 25
  start-page: 1079
  issue: 9
  year: 2016
  ident: 3534_CR60
  publication-title: Pharmacoepidemiol Drug Saf
  doi: 10.1002/pds.4043
– ident: 3534_CR89
– volume: 12
  start-page: 797
  issue: 8
  year: 1998
  ident: 3534_CR55
  publication-title: Aliment Pharmacol Ther
  doi: 10.1046/j.1365-2036.1998.00374.x
– ident: 3534_CR92
– volume: 36
  start-page: 758
  issue: 6
  year: 2019
  ident: 3534_CR42
  publication-title: Fam Pract
  doi: 10.1093/fampra/cmz025
– volume: 9
  start-page: 3728
  issue: 11
  year: 2020
  ident: 3534_CR85
  publication-title: J Clin Med
  doi: 10.3390/jcm9113728
– volume: 43
  start-page: 73
  issue: 1
  year: 2016
  ident: 3534_CR68
  publication-title: Aliment Pharmacol Ther
  doi: 10.1111/apt.13450
– volume: 94
  start-page: 260
  issue: 2
  year: 2016
  ident: 3534_CR93
  publication-title: Milbank Q.
  doi: 10.1111/1468-0009.12193
– volume: 64
  start-page: e291
  issue: 12
  year: 2016
  ident: 3534_CR56
  publication-title: Journal of the American Geriatrics Society (JAGS)
  doi: 10.1111/jgs.14528
– volume: 23
  start-page: 341
  issue: 1
  year: 2022
  ident: 3534_CR33
  publication-title: BMC Prim Care
  doi: 10.1186/s12875-022-01941-2
– volume: 24
  start-page: e52
  issue: 1
  year: 2017
  ident: 3534_CR17
  publication-title: Am J Ther
  doi: 10.1097/MJT.0000000000000154
– volume: 66
  start-page: 247
  issue: 2
  year: 2018
  ident: 3534_CR35
  publication-title: Journal of the American Geriatrics Society (JAGS)
  doi: 10.1111/jgs.15073
– ident: 3534_CR38
  doi: 10.1007/s40801-019-0157-1
– volume: 49
  start-page: 447
  issue: 5
  year: 2019
  ident: 3534_CR79
  publication-title: J Pharm Pract Res
  doi: 10.1002/jppr.1548
– ident: 3534_CR91
– volume: 70
  start-page: 2066
  issue: 11
  year: 2021
  ident: 3534_CR69
  publication-title: Gut
  doi: 10.1136/gutjnl-2020-323845
– ident: 3534_CR15
– volume: 20
  start-page: 1989
  issue: 12
  year: 2009
  ident: 3534_CR28
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-009-0891-4
– volume: 27
  start-page: 3153
  issue: 10
  year: 2016
  ident: 3534_CR78
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2015121377
– volume: 56
  start-page: 2349
  issue: 8
  year: 2011
  ident: 3534_CR67
  publication-title: Dig Dis Sci
  doi: 10.1007/s10620-011-1589-y
– ident: 3534_CR26
  doi: 10.1177/1756284820913743
– volume: 22
  start-page: 818
  issue: 1
  year: 2022
  ident: 3534_CR72
  publication-title: BMC Public Health
  doi: 10.1186/s12889-022-13217-6
– volume: 109
  start-page: 789
  issue: 6
  year: 2014
  ident: 3534_CR71
  publication-title: Am J Gastroenterol
  doi: 10.1038/ajg.2013.421
– volume: 41
  start-page: 220
  issue: 2
  year: 2016
  ident: 3534_CR61
  publication-title: J Clin Pharm Ther
  doi: 10.1111/jcpt.12371
– volume: 70
  start-page: 859
  issue: 7
  year: 2014
  ident: 3534_CR47
  publication-title: Eur J Clin Pharmacol
  doi: 10.1007/s00228-014-1681-2
– volume: 43
  start-page: 436
  issue: 12
  year: 2008
  ident: 3534_CR50
  publication-title: Formulary (Cleveland, Ohio)
– volume: 71
  start-page: 302
  issue: 5
  year: 2018
  ident: 3534_CR30
  publication-title: Canadian journal of hospital pharmacy
  doi: 10.4212/cjhp.v71i5.2839
– volume: 26
  start-page: 9
  issue: 1
  year: 2017
  ident: 3534_CR75
  publication-title: Pharmacoepidemiol Drug Saf
  doi: 10.1002/pds.4135
– volume: 63
  start-page: 871
  issue: 6
  year: 2014
  ident: 3534_CR90
  publication-title: Gut
  doi: 10.1136/gutjnl-2012-304269
– ident: 3534_CR10
– ident: 3534_CR8
  doi: 10.1016/j.japh.2020.09.015
– volume: 10
  issue: 6
  year: 2015
  ident: 3534_CR70
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0124653
– volume: 63
  start-page: 354
  issue: 5
  year: 2017
  ident: 3534_CR94
  publication-title: Can Fam Physician
– volume: 12
  start-page: 349
  year: 2019
  ident: 3534_CR31
  publication-title: Risk management and healthcare policy
  doi: 10.2147/RMHP.S223118
– volume: 67
  start-page: 2600
  issue: 12
  year: 2019
  ident: 3534_CR52
  publication-title: Journal of the American Geriatrics Society (JAGS)
  doi: 10.1111/jgs.16117
– ident: 3534_CR63
  doi: 10.1038/sj.bjc.6605024
– volume: 24
  start-page: 377
  issue: 2
  year: 2006
  ident: 3534_CR74
  publication-title: Aliment Pharmacol Ther
  doi: 10.1111/j.1365-2036.2006.02982.x
– ident: 3534_CR80
– volume: 54
  start-page: 33
  issue: 1
  year: 2012
  ident: 3534_CR39
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/cir767
– volume: 76
  start-page: 449
  issue: 3
  year: 2019
  ident: 3534_CR48
  publication-title: Eur J Clin Pharmacol
  doi: 10.1007/s00228-019-02810-1
– ident: 3534_CR3
– volume: 31
  start-page: 313
  issue: 4
  year: 2012
  ident: 3534_CR27
  publication-title: Drug Saf
  doi: 10.2165/00002018-200831040-00005
– volume: 94
  start-page: 597
  issue: 6
  year: 2014
  ident: 3534_CR29
  publication-title: Calcif Tissue Int
  doi: 10.1007/s00223-014-9855-6
– ident: 3534_CR58
  doi: 10.4212/cjhp.v71i4.2828
– volume: 30
  start-page: 1576
  issue: 11
  year: 2021
  ident: 3534_CR64
  publication-title: Pharmacoepidemiol Drug Saf
  doi: 10.1002/pds.5352
– volume: 73
  start-page: 410
  issue: 4
  year: 2016
  ident: 3534_CR34
  publication-title: JAMA Neurol
  doi: 10.1001/jamaneurol.2015.4791
– volume: 7
  issue: 7
  year: 2021
  ident: 3534_CR84
  publication-title: Heliyon
  doi: 10.1016/j.heliyon.2021.e07595
– volume: 12
  start-page: 1
  issue: 1
  year: 2012
  ident: 3534_CR19
  publication-title: BMC Health Serv Res
  doi: 10.1186/1472-6963-12-408
– ident: 3534_CR88
– volume: 24
  start-page: 559
  issue: 4
  year: 2018
  ident: 3534_CR82
  publication-title: J Neurogastroenterol Motil
  doi: 10.5056/jnm18140
– volume: 8
  start-page: 273
  issue: 9
  year: 2017
  ident: 3534_CR87
  publication-title: Ther Adv Drug Saf.
  doi: 10.1177/2042098617715381
– volume: 50
  start-page: 366
  issue: 4
  year: 2000
  ident: 3534_CR54
  publication-title: Br J Clin Pharmacol
  doi: 10.1046/j.1365-2125.2000.00262.x
– ident: 3534_CR6
– volume: 21
  start-page: S82
  year: 2018
  ident: 3534_CR4
  publication-title: Value in Health
  doi: 10.1016/j.jval.2018.04.560
– ident: 3534_CR9
– volume: 43
  start-page: 323
  issue: 4
  year: 2009
  ident: 3534_CR1
  publication-title: J Clin Gastroenterol
  doi: 10.1097/MCG.0b013e31818a386e
– volume: 20
  start-page: 171
  issue: 2
  year: 2009
  ident: 3534_CR5
  publication-title: Eur J Intern Med
  doi: 10.1016/j.ejim.2007.10.020
– volume: 17
  start-page: 15
  issue: 1
  year: 2009
  ident: 3534_CR41
  publication-title: Qual Prim Care
– ident: 3534_CR12
– volume: 42
  start-page: e68
  issue: 5
  year: 2010
  ident: 3534_CR32
  publication-title: Intern Med J
  doi: 10.1111/j.1445-5994.2010.02259.x
– volume: 14
  start-page: 175628482199892
  year: 2021
  ident: 3534_CR57
  publication-title: Therap Adv Gastroenterol
  doi: 10.1177/1756284821998928
– reference: 37725121 - Eur J Clin Pharmacol. 2023 Nov;79(11):1579-1581. doi: 10.1007/s00228-023-03564-7.
SSID ssj0015903
Score 2.6405554
SecondaryResourceType review_article
Snippet Purpose Proton pump inhibitors (PPIs) reduce acid secretion in the stomach and rank as one of the most widely used acid-suppressing medicines globally. While...
Proton pump inhibitors (PPIs) reduce acid secretion in the stomach and rank as one of the most widely used acid-suppressing medicines globally. While PPIs are...
PurposeProton pump inhibitors (PPIs) reduce acid secretion in the stomach and rank as one of the most widely used acid-suppressing medicines globally. While...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1159
SubjectTerms Adult
Biomedical and Life Sciences
Biomedicine
Catalysts
Female
Health Care Costs
Humans
Male
Pharmacology/Toxicology
Prescriptions
Proton pump inhibitors
Proton Pump Inhibitors - adverse effects
Review
Reviews
Systematic review
Upper Gastrointestinal Tract
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagXLgg3gQKMhLqhbVI4kccLgghqgoE2kMr7S2KnbG6UpUsm91D--vxOE6ipaLHyI4S55vxTDwz3xDywZiiVLqpGaTcMgFNzuqSSyZkDlpJq8DhOeSv3-rsQvxYyVU8cOtjWuW4J4aNuuksnpF_yjWaNlHq9MvmD8OuURhdjS007pMHSF2GUl2sph8ub6nTSLqbMVUWaSyaCaVzgfiFeYvFUi65YDeHhumWt3k7afKfyGkwSKePyaPoSdKvA_RPyD1on5KT5UBFfb2g53NlVb-gJ3Q5k1RfPyM_l9vOu3104-Gk6_Zybbxqb-m-h890ZnemQ2UL7RwdmEPoLuTQ0rpt6Fhg1T8nF6ffz7-dsdhYgVlRyB2zBTgoM6vBaa-CAJlx0nJj0rpQ1jsYAtIccmOk9g4hButKq5z3TJQThVGcvyBHbdfCK0Ibvz_6zdbVKQByvZUKNOfOX2EI1kBCsvGrVjayjmPzi6tq4ksOSFQeiSogUd0k5ON0z2bg3Lhz9vEIVhX1r69maUnI-2nYaw6GQ-oWuj3O8c4n8uGphLwcsJ0exwuByWZlQvQB6tMEZOU-HGnXl4GdO8PuJVLKhCxGAZnf6__LeH33Mt6Qh3kQVsxuOyZHu-0e3np3aGfeBZn_C7oPB9g
  priority: 102
  providerName: ProQuest
Title Proton pump inhibitor use: systematic review of global trends and practices
URI https://link.springer.com/article/10.1007/s00228-023-03534-z
https://www.ncbi.nlm.nih.gov/pubmed/37420019
https://www.proquest.com/docview/2850914980
https://www.proquest.com/docview/2835279956
https://pubmed.ncbi.nlm.nih.gov/PMC10427555
Volume 79
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9tAEB6a5NJLafpUm5otlFzqBUn70uZmG7uhocaUGNyT0K5niSHIwY9D8uu7K8kyTtpCL1rEjp7fjvZDM_MtwBdjlJbZvKAYM0s5zlNaaCYoFylmUliJLvyH_DGWl1P-fSZmjUxOqIV5FL8PYp9p0FBOGY2ZYJw-HMGJSJgKyzQM5KCNGAgdNwK7CZVaxU2BzJ_PcTgJPWGWTxMkH0VJq8ln9BJeNKyR9GqYT-EZlq_gfFLLTt93yfW-imrdJedkshekvn8NV5PV0lM8cuehI4vyZmG8G6_Ido0XZK_kTOoqFrJ0pFYJIZsqX5YU5ZzsiqnWb2A6Gl4PLmmziAK1XIkNtQod6sRm6DLvboiJccIyY-JCSevJBMc4xdQYkXnyFwJz2krnWYh0XBnJ2Fs4Lpclvgcy999C_2F1RYwYdN20xIwx5_dCuNVgBMnurea2URgPC13c5q02coVE7pHIKyTyhwi-tsfc1foa_7Q-24GVN762ztMskB6usziCz22395IQ-ihKXG6DjSeaQftORvCuxra9HFM8JJbpCLID1FuDoMB92FMubiol7iSsVCKEiKC7GyD7-_r7Y3z4P_OP8DytBm_IbDuD481qi588FdqYDhypmerASW_U749D--3X1dC3_eF48rNTeYjfTtPebyDLB4c
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB5V5QAXxJtAASNBL6xFXnYSJIQQUG3ZttrDVtpbiJ2JuhJKls2u0PZH8RsZOy8tFb31GMVREs_nmbFn5huAN0pFiYzzjKMbaB5i7vMsCQQPhY-xFFpiYc4hT8_k-Dz8PhfzPfjT1cKYtMpOJ1pFnVfanJG_92Nj2sIkdj8tf3HTNcpEV7sWGg0sJrj9TVu2-uPxV5LvW98_-jb7MuZtVwGuw0isuY6wwMTTMRYx4Q_RU4XQgVJuFklN1jVE10dfKRGTN2QiVYmWBZllWYSRkuYAlFT-LTK8rtnsRfN-g0eegduS_HpcJpHbFunYUj1LNMPJQnI3EEHIL3cN4RXv9mqS5j-RWmsAj-7B3dZzZZ8bqN2HPSwfwOG0ob7ejthsqOSqR-yQTQdS7O1DmExXFbmZbEnwYYvyYqFIlazYpsYPbGCTZk0lDasK1jCVsLXN2WVZmbOuoKt-BOc3MuWPYb-sSnwKLCd9TMq9yFxEwy2XSIyDoKArE_JV6IDXzWqqW5Zz02zjZ9rzM1tJpCSJ1EoivXTgXf_MsuH4uHb0QSestF3vdTqg04HX_W1aqSb8kpVYbcwYcnYN_5504Ekj2_51QRSa5LbEgXhH6v0AwwK-e6dcXFg2cM90SxFCODDqADJ81_9_49n1v_EKbo9npyfpyfHZ5Dnc8S1wTWbdAeyvVxt8Qa7YWr20-Gfw46YX3F-RqkST
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9RAFD6ULYgv4t1o1RG0L-7Q3GaSEUTUdmldXYK00LeYmZyhC5Ksm11k-9P8dc7kylrsWx_DTEhmznXmnPMdgNdSRoLHeUbRDRQNMfdpJgJGQ-ZjzJniqO095LcZPz4Lv5yz8x3409XC2LTKTifWijovlb0jP_Bja9pCEbsHuk2LSA4nHxa_qO0gZSOtXTuNhkWmuPltjm_V-5NDQ-s3vj85Ov18TNsOA1SFEVtRFaFG4akYdWx4EdGTmqlASjeLuDKWNkTXR19KFhvPyEathOLamGiuw0hyexlq1P9uZE9FI9j9dDRLvvcxDCbcFvLXo1xEbluyUxfu1bAz1NhL6gYsCOnltlm84uteTdn8J25bm8PJXbjT-rHkY8N492AHi_uwnzRA2JsxOR3quqox2SfJAJG9eQDTZFkap5MsDDOReXExl0axLMm6wndkwJYmTV0NKTVpcEvIqs7gJVmRk668q3oIZzey6Y9gVJQFPgGSG-1sVL3OXESLNCc4xkGgzZMNAEt0wOt2NVUt5rltvfEz7dGaa0qkhhJpTYn00oG3_TuLBvHj2tl7HbHSVvqrdOBVB171w0ZubTAmK7Bc2znG9bVofNyBxw1t-88FUWhT3YQD8RbV-wkWE3x7pJhf1Njgnu2dwhhzYNwxyPBf_1_G0-uX8RJuGWFLv57Mps_gtl_zrU2z24PRarnG58YvW8kXrQAQ-HHTMvcXTjtKLg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Proton+pump+inhibitor+use%3A+systematic+review+of+global+trends+and+practices&rft.jtitle=European+journal+of+clinical+pharmacology&rft.au=Shanika%2C+Lelwala+Guruge+Thushani&rft.au=Reynolds%2C+Andrew&rft.au=Pattison%2C+Sharon&rft.au=Braund%2C+Rhiannon&rft.date=2023-09-01&rft.eissn=1432-1041&rft.volume=79&rft.issue=9&rft.spage=1159&rft_id=info:doi/10.1007%2Fs00228-023-03534-z&rft_id=info%3Apmid%2F37420019&rft.externalDocID=37420019
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0031-6970&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0031-6970&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0031-6970&client=summon